News

Deal Announcements

Intarcia Closes $50 Million Series BB Round

Monday, March 19, 2007 7:00:00 AM PDT | VentureDeal Staff
EMERYVILLE, CA -- Intarcia announced the close of its series BB round, raising $50 million in new investment.

The company is in ongoing clinical development for its Omega DUROS (R) therapy for chronic hepatitis C, and intends to also use the proceeds to advance its diabetes program to phase I clinical trials.

The round was led by new investor New Leaf Ventures and included another new investor, Quilvest Ventures.  Existing investors who joined the round were New Enterprise Associates, Venrock Associates, Alta Partners, Omega Fund and Granite Global Ventures.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1